A recent study reported a 31.8% reduction in clinically diagnosed uterine leiomyoma in hypertensive adult women who had previously used angiotensin-converting enzyme inhibitors (ACEis) compared with those who had not used ACEis (55). The gene discussed is ACE; the disease is uterine corpus leiomyoma.